[Non-invasive neurostimulation in migraine]

Area of Science:

• Neurology
• Neuroscience
• Medical Devices

Background:

• Migraine is a leading cause of disability and reduced quality of life globally.
• Chronic neurological disorders like migraine necessitate innovative treatment strategies.
• Neuromodulation is an emerging therapeutic approach for primary headaches.

Purpose of the Study:

• To review the clinical evidence on non-invasive neuromodulation for migraine.
• To evaluate the safety and efficacy of stimulating the first branch of the trigeminal nerve.
• To assess the potential of this technique in managing migraine.

Main Methods:

• Systematic review of clinical trials and case reports.
• Analysis of studies investigating non-invasive first branch trigeminal nerve stimulation (FBTNS).
• Assessment of reported outcomes related to migraine frequency, intensity, and quality of life.

Main Results:

• Non-invasive FBTNS has demonstrated effectiveness in various migraine types.
• Studies indicate a favorable safety profile for this neuromodulation technique.
• Evidence suggests potential benefits for reducing migraine burden and improving patient well-being.

Conclusions:

• Non-invasive first branch trigeminal nerve stimulation is a promising therapeutic option for migraine management.
• Further research and clinical implementation are warranted to optimize its use.
• This approach represents a significant advancement in non-pharmacological migraine treatment.